109
Views
23
CrossRef citations to date
0
Altmetric
Obstetrics

Massive postpartum haemorrhage as a cause of maternal morbidity in a large tertiary hospital

, , &
Pages 519-520 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Slawomir Sobieszczyk, Grzegorz H. Bręborowicz, Viliyan Platicanov, Stoyan Tanchev & Craig M. Kessler. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstetricia et Gynecologica Scandinavica 85:10, pages 1239-1247.
Read now

Articles from other publishers (22)

Shermin Siria BegamDr.Dr., Anuradha GhoshDr.Dr., MD NurejjamanDr.Dr. & Debarshi janaDr.Dr.. (2021) EFFECT OF PREOPERATIVE SUBLINGUAL MISOPROSTOL IN REDUCING INTRA AND POST-OPERATIVE BLOOD LOSS IN CESAREAN SECTION - A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 60-62.
Crossref
Olufemi T Oladapo, Jennifer Blum, Edgardo Abalos & Babasola O Okusanya. (2020) Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Essam Rashad Othman, Margaret Fathy Fayez, Diaa Eldeen Mohamed Abd El Aal, Hazem Saad El-Dine Mohamed, Ahmed Mohammed Abbas & Mohammed Khairy Ali. (2016) Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial. Taiwanese Journal of Obstetrics and Gynecology 55:6, pages 791-795.
Crossref
N. H. L. Jensen, J. Stensballe & A. Afshari. (2016) Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review. Acta Anaesthesiologica Scandinavica 60:8, pages 1033-1042.
Crossref
Sonal Kulshreshtha, Pratibha Garg & Deepika Dhurvey. (2016) A RETROSPECTIVE STUDY OF MATERNAL MORTALITY DUE TO POSTPARTUM HAEMORRHAGE OVER THE PERIOD OF LAST 10 YEARS IN A TERTIARY CARE CENTRE. Journal of Evolution of Medical and Dental Sciences 5:40, pages 2448-2451.
Crossref
Mohamed A. Mohamed, Aseem A. Abdo, Mohamed E. Ahmed & Haitham A. Torky. (2016) Prophylactic B-Lynch suture (modified technique) versus prophylactic carbetocin and prophylactic oxytocin during cesarean section in women at high risk for atonic postpartum hemorrhage. Evidence Based Womenʼs Health Journal 6:2, pages 37-41.
Crossref
Jerrold H. Levy & Lawrence T. Goodnough. (2015) How I use fibrinogen replacement therapy in acquired bleeding. Blood 125:9, pages 1387-1393.
Crossref
Jerrold H. Levy, Ian Welsby & Lawrence T. Goodnough. (2014) Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 54:5, pages 1389-1405.
Crossref
Andrew J. Dilla, Jonathan H. Waters & Mark H. Yazer. (2013) Clinical Validation of Risk Stratification Criteria for Peripartum Hemorrhage. Obstetrics & Gynecology 122:1, pages 120-126.
Crossref
VEDRAN STEFANOVIC, JORMA PAAVONEN, MIKKO LOUKOVAARA, ERJA HALMESMÄKI, JOUNI AHONEN & MINNA TIKKANEN. (2013) Intravenous sulprostone infusion in the treatment of retained placenta. Acta Obstetricia et Gynecologica Scandinavica 92:4, pages 426-432.
Crossref
Olufemi T Oladapo, Bukola Fawole, Jennifer Blum & Edgardo Abalos. (2012) Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database of Systematic Reviews.
Crossref
Jerrold H. Levy, Fania Szlam, Kenichi A. Tanaka & Roman M. Sniecienski. (2012) Fibrinogen and Hemostasis. Anesthesia & Analgesia 114:2, pages 261-274.
Crossref
Olufemi T Oladapo, Bukola Fawole, Jennifer Blum & Edgardo Abalos. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Myriam Oudghiri, Hawa Keïta, Edwige Kouamou, Mathieu Boutonnet, Mattea Orsini, Céline Desconclois, Laurent Mandelbrot, Jean-Pierre Daurès, Alain Stépanian, Edith Peynaud-Debayle & Dominique de Prost. (2017) Reference values for rotation thromboelastometry (ROTEM®) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters. Thrombosis and Haemostasis 106:07, pages 176-178.
Crossref
MASSIMO FRANCHINI, MASSIMO FRANCHI, VALENTINO BERGAMINI, MARTINA MONTAGNANA, GIAN LUCA SALVAGNO, GIOVANNI TARGHER & GIUSEPPE LIPPI. (2010) The Use of Recombinant Activated FVII in Postpartum Hemorrhage. Clinical Obstetrics & Gynecology 53:1, pages 219-227.
Crossref
Giovanni Barillari, Maria Grazia Frigo, Maddalena Casarotto, Antonio Farnia, Barbara Massè, Roberto Wetzl, Andrea Bianchin, Andras Rabi, Paolo Malacarne, Samantha Pasca & Enrico Bigotto. (2009) Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry. Thrombosis Research 124:6, pages e41-e47.
Crossref
Iqbal Al-Zirqi, Siri Vangen, Lisa Forsén & Babill Stray-Pedersen. (2009) Effects of onset of labor and mode of delivery on severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology 201:3, pages 273.e1-273.e9.
Crossref
C. CHAULEUR, E. COCHERY‐NOUVELLON, E. MERCIER, G. AYA, P. FABBRO‐PERAY, P. MISMETTI, G. LISSADE‐LAVIGNE & J.C. GRIS. (2008) Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. Journal of Thrombosis and Haemostasis 6:12, pages 2067-2074.
Crossref
Guillermo Carroli, Cristina Cuesta, Edgardo Abalos & A. Metin Gulmezoglu. (2008) Epidemiology of postpartum haemorrhage: a systematic review. Best Practice & Research Clinical Obstetrics & Gynaecology 22:6, pages 999-1012.
Crossref
I Al-Zirqi, S Vangen, L Forsen & B Stray-Pedersen. (2008) Prevalence and risk factors of severe obstetric haemorrhage. BJOG: An International Journal of Obstetrics & Gynaecology 115:10, pages 1265-1272.
Crossref
B. CHARBIT, L. MANDELBROT, E. SAMAIN, G. BARON, B. HADDAOUI, H. KEITA, O. SIBONY, D. MAHIEU‐CAPUTO, M.F. HURTAUD‐ROUX, M.G. HUISSE, M.H. DENNINGER & D. DE PROST. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 5:2, pages 266-273.
Crossref
Catalin S Buhimschi & Irina A Buhimschi. (2006) Advantages of Vaginal Delivery. Clinical Obstetrics and Gynecology 49:1, pages 167-183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.